Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Hammel

Showing results (71-80 of 241) with videos related to

Pageof 25
Sort By:
The American Journal of Gastroenterology|January 11, 2008
Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive seriesVinciane Rebours, Marie-Christine Boutron-Ruault, Matthieu Schnee, et al.
Annals of Surgery|December 6, 2005
Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluationAnne Couvelard, Alain Sauvanet, Reza Kianmanesh, et al.
Gastrointestinal Endoscopy|February 8, 2011
Epidermoid carcinoma complicating esophageal lichen planus without cutaneous or oral involvementAlain Aubert, Pascal Hammel, Thierry Perniceni, et al.
Surgery|February 27, 2017
Surgery for pancreatic neoplasms: How accurate are our surgical indications?David Jérémie Birnbaum, Sébastien Gaujoux, Julie Berbis, et al.
Pancreas|November 15, 2011
Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreasOlivier Corcos, Anne Couvelard, Delphine Dargère, et al.
Targeted Oncology|August 28, 2012
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategiesAnnemilaï Tijeras-Raballand, Cindy Neuzillet, Anne Couvelard, et al.
United European Gastroenterology Journal|July 4, 2020
Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatmentsLina Aguilera Munoz, Louis de Mestier, Hanah Lamallem, et al.
Hepatobiliary Surgery and Nutrition|December 1, 2018
Adjuvant chemotherapy with gemcitabine plus erlotinib <i>vs.</i> gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?-review of the open label phase III trial CONKO 005Mathilde Wisniewski, Pierre-Alain Placide, Sandra Granier, et al.
World Journal of Gastroenterology|June 18, 2010
Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumorCindy Neuzillet, Céline Lepère, Mostafa El Hajjam, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 13, 2010
CFTR gene mutation in patients with apparently idiopathic pancreatitis: lack of phenotype-genotype correlationAnne-Laure Pelletier, Thierry Bienvenu, Vinciane Rebours, et al.
Pageof 25

Showing results (71-80 of 241) with videos related to

Sort By:
Pageof 25
The American Journal of Gastroenterology|January 11, 2008
Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive seriesVinciane Rebours, Marie-Christine Boutron-Ruault, Matthieu Schnee, et al.
Annals of Surgery|December 6, 2005
Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluationAnne Couvelard, Alain Sauvanet, Reza Kianmanesh, et al.
Gastrointestinal Endoscopy|February 8, 2011
Epidermoid carcinoma complicating esophageal lichen planus without cutaneous or oral involvementAlain Aubert, Pascal Hammel, Thierry Perniceni, et al.
Surgery|February 27, 2017
Surgery for pancreatic neoplasms: How accurate are our surgical indications?David Jérémie Birnbaum, Sébastien Gaujoux, Julie Berbis, et al.
Pancreas|November 15, 2011
Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreasOlivier Corcos, Anne Couvelard, Delphine Dargère, et al.
Targeted Oncology|August 28, 2012
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategiesAnnemilaï Tijeras-Raballand, Cindy Neuzillet, Anne Couvelard, et al.
United European Gastroenterology Journal|July 4, 2020
Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatmentsLina Aguilera Munoz, Louis de Mestier, Hanah Lamallem, et al.
Hepatobiliary Surgery and Nutrition|December 1, 2018
Adjuvant chemotherapy with gemcitabine plus erlotinib <i>vs.</i> gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?-review of the open label phase III trial CONKO 005Mathilde Wisniewski, Pierre-Alain Placide, Sandra Granier, et al.
World Journal of Gastroenterology|June 18, 2010
Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumorCindy Neuzillet, Céline Lepère, Mostafa El Hajjam, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 13, 2010
CFTR gene mutation in patients with apparently idiopathic pancreatitis: lack of phenotype-genotype correlationAnne-Laure Pelletier, Thierry Bienvenu, Vinciane Rebours, et al.
Pageof 25